The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
What’s Next For JD.com Stock After The Pullback?
JD.com Inc. (NASDAQ: CODX) shares fell Monday as many Chinese companies trade lower following reports the U.S.-China relationship is in a “stalemate” after a meeting between officials from the two countries.
75 Biggest Movers From Friday
Gainers
The New Home Company Inc. (NYSE: NWHM) jumped 82.9% to settle at $8.89 on Friday after the company agreed to be acquired by funds managed by affiliates of Apollo Global Management for $9 per share in all-cash transaction.
50 Stocks Moving In Friday’s Mid-Day Session
Gainers
Xenetic Biosciences Inc (NASDAQ: XBIO) shares jumped 111.3% to $3.9299 on abnormally-high volume.
Co-Diagnostics Shares Move Lower; Traders Circulate Earlier Salt Lake Tribune Titled ‘SEC investigators made inquiries about COVID-19 tests sold by Utah company, The Salt Lake Tribune has learned’
https://www.sltrib.com/news/2021/06/17/sec-investigators-made/
74 Biggest Movers From Friday
Gainers
MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter.
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 13)
